Patent 7635487 was granted and assigned to Intercell on December, 2009 by the United States Patent and Trademark Office.
The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae, methods for isolating such antigens and specific uses thereof.